LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

LLY

734.37

-0.09%↓

JNJ

176.67

-0.01%↓

ABBV

208.05

-0.2%↓

UNH

303.9

+1.02%↑

AZN

79.94

-0.17%↓

Search

Avanos Medical Inc

Închisă

SectorSănătate

11.79 1.99

Rezumat

Modificarea prețului

24h

Curent

Minim

11.39

Maxim

11.89

Indicatori cheie

By Trading Economics

Venit

-83M

-77M

Vânzări

7.5M

175M

P/E

Medie Sector

33.255

35.724

EPS

0.141

Marjă de profit

-43.886

Angajați

2,227

EBITDA

-85M

-64M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-5.01% downside

Dividende

By Dow Jones

Următoarele câștiguri

29 oct. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

18M

538M

Deschiderea anterioară

9.8

Închiderea anterioară

11.79

Sentimentul știrilor

By Acuity

25%

75%

44 / 372 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

Avanos Medical Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 aug. 2025, 22:51 UTC

Câștiguri

Wesfarmers Plans Special Payout to Shareholders as Annual Net Profit Rises 14%

27 aug. 2025, 23:57 UTC

Câștiguri

Trip.com Group 1H Rev $4.01B

27 aug. 2025, 23:57 UTC

Câștiguri

Trip.com Group 1H Adj EPS $1.84

27 aug. 2025, 23:57 UTC

Câștiguri

Trip.com Group 1H EPS $1.82

27 aug. 2025, 23:50 UTC

Market Talk

Nikkei May Decline Amid Caution Over Tariff Impact, Chip Demand -- Market Talk

27 aug. 2025, 23:39 UTC

Câștiguri

Correction to Nvidia Earnings Article -- WSJ

27 aug. 2025, 22:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 aug. 2025, 22:59 UTC

Market Talk

HP CEO Sees Strong Back-to-School Spending on PCs -- Market Talk

27 aug. 2025, 22:58 UTC

Câștiguri

South32 Records Significant Items of $71 Million Tied to Worsley, Mozal

27 aug. 2025, 22:57 UTC

Câștiguri

South32 FY Free Cash Flow $192 Million

27 aug. 2025, 22:56 UTC

Câștiguri

South32 FY Total Capital Expenditure $1.35 Billion

27 aug. 2025, 22:56 UTC

Câștiguri

South32 FY Capital Expenditure $963 Million, Excluding EAIs

27 aug. 2025, 22:55 UTC

Câștiguri

South32 Net Cash $123 Million at June 30

27 aug. 2025, 22:54 UTC

Câștiguri

South32: Focused on Maintaining Strong Operating Momentum

27 aug. 2025, 22:53 UTC

Câștiguri

South32: $144 Million Remains to be Returned to Shareholders Under Program

27 aug. 2025, 22:53 UTC

Câștiguri

South32 Extends Capital Management Program for 12 Months

27 aug. 2025, 22:52 UTC

Câștiguri

South32 FY Underlying Ebitda $1.93 Billion, Up 7% On-Year

27 aug. 2025, 22:51 UTC

Câștiguri

South32 FY Revenue $5.78 Billion, Up 17% On-Year

27 aug. 2025, 22:51 UTC

Câștiguri

South32 FY Underlying Earnings $666 Million, Up 75% On-Year

27 aug. 2025, 22:50 UTC

Câștiguri

South32 to Pay Final Dividend of 2.6 U.S. Cents/Share

27 aug. 2025, 22:50 UTC

Câștiguri

South32 FY Net Profit $213 Million Vs $203 Million Loss Year Earlier

27 aug. 2025, 22:45 UTC

Câștiguri

Sandfire Resources Expects FY26 Matsa Capital Expenditure of $148 Million

27 aug. 2025, 22:44 UTC

Câștiguri

Sandfire Resources Expects FY26 Motheo Unit Cost of $44/Ton of Ore Processed

27 aug. 2025, 22:44 UTC

Câștiguri

Sandfire Resources Expects FY26 Motheo Capital Expenditure of $82 Million

27 aug. 2025, 22:43 UTC

Câștiguri

Sandfire Resources Expects FY26 Matsa Unit Cost of $86/Ton of Ore Processed

27 aug. 2025, 22:43 UTC

Câștiguri

Nvidia Breaks Sales Record Despite Chinese Trade Hiccups -- 5th Update

27 aug. 2025, 22:42 UTC

Câștiguri

Sandfire Resources Expects FY26 Motheo Copper Eq Output to Rise 3% to 61,000 Tons

27 aug. 2025, 22:42 UTC

Câștiguri

Sandfire Resources Expects FY26 Matsa Copper Eq Output to Rise 2% to 96,000 Tons

27 aug. 2025, 22:40 UTC

Câștiguri

Sandfire Resources Net Debt $123 Million at June 30

27 aug. 2025, 22:40 UTC

Câștiguri

Sandfire Resources FY Underlying Ebitda $527.7 Million

Comparație

Modificare preț

Avanos Medical Inc Așteptări

Obiectiv de preț

By TipRanks

-5.01% jos

Prognoză pe 12 luni

Medie 11 USD  -5.01%

Maxim 11 USD

Minim 11 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAvanos Medical Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

1 ratings

0

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

12.28 / 12.71Suport & Rezistență

Termen scurt

Very Strong Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

44 / 372 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.